Evidence map›Paper›PMID 38446860›Full record

ArticleJournal of addiction medicine

Impact of Nicotine Replacement Therapy Sampling on Cessation-Related Processes.

Michelle L Sisson, Jamie M Gajos, Caitlin Wolford-Clevenger, Keith R Chichester, Elizabeth S Hawes, Samantha V Hill, Richard C Shelton, Peter S Hendricks, Michael S Businelle, Matthew J Carpenter and 1 more

Abstract read
In one paragraph

Article in Journal of addiction medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Michelle L SissonFrom the Department of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, Birmingham, AL (MLS, CW-C, KRC, ESH, RCS, KLC); Department of Family and Community Medicine, University of Alabama at Birmingham, Birmingham, AL (JMG); Department of Pediatrics, School of Medicine, University of Alabama at Birmingham, Birmingham, AL (SVH); Department of Health Behavior, School of Public Health, University of Alabama at Birmingham, Birmingham, AL (PSH); Health Promotion Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK (MSB); and Department of Psychiatry and Behavioral Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC (MJC).
Jamie M Gajos
Caitlin Wolford-Clevenger
Keith R Chichester
Elizabeth S Hawes
Samantha V Hill
Richard C Shelton
Peter S Hendricks
Michael S Businelle
Matthew J Carpenter
Karen L Cropsey

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI ROBERT S. MANNEL · 2018 to 2026
$27.1M
NRT sampling and selection to Increase Medication AdherenceR34DA043346 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L · 2017 to 2019
$668k
NCI NIH HHS P30 CA225520NIDA NIH HHS R34 DA043346
6 · The paper itself

Abstract

objectivesSmoking prevalence remains high among low-income smokers. Understanding processes (eg, withdrawal, craving, motivation) in early smoking cessation is crucially important for designing effective interventions for this population.

methodsThis is a secondary analysis of a novel, in-session sampling intervention (ie, In Vivo) as compared with standard care behavioral smoking cessation counseling (SC) among community-dwelling low-income smokers (n = 83). This analysis examined the effect of 5 in-session sampling interventions on cessation-related processes and perceived advantages or disadvantages of nicotine replacement therapy (NRT) products over time using daily diaries.

resultsThe In Vivo treatment had an early positive impact in terms of decreasing withdrawal symptoms and cravings, and increasing perceived advantages to NRT, with moderate to large effect sizes. Results also showed that the treatment effectively reduced withdrawal symptoms and cravings in-session, with small-to-medium and medium-to-large effect sizes, respectively. In-session reduction of withdrawal symptoms and cravings did not occur for the SC group, with the exception of decreased withdrawal symptoms occurring during week 4. The In Vivo treatment did not impact quit goal, desire to quit, abstinence self-efficacy, perceived difficulty in quitting, motivational engagement, or perceived disadvantages to NRT. The In Vivo group reported less daily cigarette use relative to the SC group, in addition to reporting less cigarette use on days they reported greater combination NRT use.

conclusionsThere is preliminary support for this In Vivo treatment over SC in reducing withdrawal, craving, and the number of cigarettes smoked per day, as well as promoting perceived advantages of NRT among low-income smokers.

Indexed as

CravingSmoking CessationSubstance Withdrawal SyndromeTobacco Use Cessation DevicesAdultCounselingFemaleHumansMaleMiddle AgedMotivationNicotine Replacement TherapyPoverty

Identifiers

PMID38446860
PMCPMC11290993

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.